<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Guo Z</submitter><funding>The Key projects of Qilu Hospital (Qingdao) Foundation</funding><pagination>41774</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12647232</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Intracranial aneurysm (IA) is a type of cerebrovascular complication that can result in subarachnoid hemorrhage. Published research have evidenced the involvement of METTL3, a critical mRNA m&lt;sup>6&lt;/sup>A methyltransferase, in the generation of various cardiovascular diseases. However, its specific role in regulating IAs remains unclear. Our research demonstrated downregulation of METTL3 in IA patients and a significant positive correlation with AMPK expression. In vascular smooth muscle cells (VSMCs), overexpressing METTL3 led to an upregulation of contractile marker genes (SM-22α &amp; α-SMA), while the expressions of TNF-α, IL-1β, iNOS, IL-6, MMP-9, and MMP-3 were significantly downregulated. This effect was reversed by the use of the AMPK inhibitor Compound C. Therefore, it can be postulat</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>METTL3 promotes vascular stability in intracranial aneurysm via m6A-AMPK axis.</pubmed_title><pmcid>PMC12647232</pmcid><funding_grant_id>QDKY2020ZD01</funding_grant_id><pubmed_authors>Guo Z</pubmed_authors><pubmed_authors>Zhong Y</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Ming Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>METTL3 promotes vascular stability in intracranial aneurysm via m6A-AMPK axis.</name><description>Intracranial aneurysm (IA) is a type of cerebrovascular complication that can result in subarachnoid hemorrhage. Published research have evidenced the involvement of METTL3, a critical mRNA m&lt;sup>6&lt;/sup>A methyltransferase, in the generation of various cardiovascular diseases. However, its specific role in regulating IAs remains unclear. Our research demonstrated downregulation of METTL3 in IA patients and a significant positive correlation with AMPK expression. In vascular smooth muscle cells (VSMCs), overexpressing METTL3 led to an upregulation of contractile marker genes (SM-22α &amp; α-SMA), while the expressions of TNF-α, IL-1β, iNOS, IL-6, MMP-9, and MMP-3 were significantly downregulated. This effect was reversed by the use of the AMPK inhibitor Compound C. Therefore, it can be postulat</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T16:41:24.066Z</modification><creation>2026-05-18T03:12:56.734Z</creation></dates><accession>S-EPMC12647232</accession><cross_references><pubmed>41290742</pubmed><doi>10.1038/s41598-025-25685-y</doi></cross_references></HashMap>